GlassScriptPhysician profile
Donald Thomas Mcknight
NPI 1225011588
$5,875.14
in general payments reported to CMS, 2019-2025
44 companies · $1,715 in 2025
The $1,715 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $126 · 2021: $461 · 2022: $993 · 2023: $935 · 2024: $1,068 · 2025: $1,715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,442 · Education: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,442.47 |
| Education | $274.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $877.02 | 2019-2025 | Myrbetriq, Xtandi |
| Abbvie INC. | $707.64 | 2019-2025 | |
| Boston Scientific Corporation | $532.61 | 2019-2025 | General - Erectile Dysfunction, Lithovue, Advantage System |
| Teleflex LLC | $350.21 | 2021-2025 | Urolift |
| Urogen Pharma, INC. | $326.10 | 2023-2025 | Jelmyto |
| Janssen Biotech, INC. | $313.87 | 2021-2025 | Erleada, Balversa, Akeega |
| Dendreon Pharmaceuticals LLC | $277.44 | 2024-2025 | Provenge |
| Endo Pharmaceuticals INC. | $174.88 | 2019-2023 | Xiaflex |
| Sumitomo Pharma America, INC. | $167.98 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $166.60 | 2022-2025 | |
| Neotract INC. | $152.19 | 2019 | |
| Telix Pharmaceuticals | $128.96 | 2024 | Illuccix |
| Merck Sharp & Dohme LLC | $119.44 | 2019-2025 | Keytruda, Lynparza |
| Coloplast Corp | $119.38 | 2021-2025 | Speedicath |
| Laborie Medical Technologies Corp. | $115.81 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Mcknight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.